SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-17-013047
Filing Date
2017-12-11
Accepted
2017-12-08 21:29:16
Documents
8

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-1 fs12017a1_akersbiosciences.htm S-1/A 6058571
2 FORM OF CERTIFICATE OF SERIES B PREFERRED STOCK DESIGNATION fs12017a1ex3-7_akersbiosci.htm EX-3.7 109914
3 OPINION OF LUCOSKY BROOKMAN LLP fs12017a1ex5-1_akersbiosci.htm EX-5.1 14475
4 CONSENT OF MORISONCOGEN, DATED DECEMBER 8, 2017 fs12017a1ex23-1_akersbiosci.htm EX-23.1 2339
5 GRAPHIC ex5-1_001.jpg GRAPHIC 39077
6 GRAPHIC ex5-1_002.jpg GRAPHIC 11788
7 GRAPHIC image001.jpg GRAPHIC 21467
8 GRAPHIC image002.jpg GRAPHIC 445960
  Complete submission text file 0001213900-17-013047.txt   6900773
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-221746 | Film No.: 171248253
SIC: 2835 In Vitro & In Vivo Diagnostic Substances